Trial: 202112103

A Phase 1/ 2 Study of BAY 1895344 (elimusertib, IND#152153, NSC#810486) in Pediatric Patients with Relapsed or Refractory Solid Tumors

Phase

I/II

Principal Investigator

Hayashi, Robert

Disease Site

Anus; Bones and Joints; Breast; Cervix; Colon; Corpus Uteri; Esophagus; Eye and Orbit; Hodgkin Lymphoma; Kidney; Larynx; Lip, Oral Cavity and Pharynx; Lung; Melanoma, Skin; Non-Hodgkin Lymphoma; Ovary; Pancreas; Prostate; Rectum; Small Intestine; Soft Tissue; Stomach; Thyroid; Urinary Bladder

Learn more about this study at: clinicaltrials.gov